Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 2, 2000, Pages 538-544

  Pyörälä, Marja ^a   Miettinen, Heikki ^a   Halonen, Pirjo ^a   Laakso, Markku ^a   Pyörälä, Kalevi ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Coronary disease; Epidemiology; Insulin; Insulin resistance syndrome; Stroke

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FACTORIAL ANALYSIS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; ORAL GLUCOSE TOLERANCE TEST; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; SKINFOLD THICKNESS; SMOKING;

EID: 0343485089     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.2.538     Document Type: Article

References (42)

1. Ruige JB, Assendelft WJJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. Insulin and risk of cardiovascular disease: a meta-analysis. Circulation. 1998;97:996-1001.
2. Pyörälä M, Miettinen H, Laakso M, Pyörälä K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation. 1998;98: 398-404.
3. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke. 1994;25:1157-1164.
4. Burchfiel CM, Rodriguez BL, Abbott RD, Sharp DS, Curb JD. Insulin levels and risk of stroke. Circulation. 1998;97:824. Abstract.
5. Pyörälä M, Miettinen H, Laakso M, Pyörälä K. Hyperinsulinemia and the risk of stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Stroke. 1998;29:1860-1866.
6. Folsom AR, Rasmussen ML, Chambles LE, Howard G, Cooper LS, Schmidt MI, Heiss G. for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Prospective association of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. Diabetes Care. 1999;22:1077-1083.
7. Stout RW. Insulin and atheroma: 20-yr perspective. Diabetes Care. 1990; 13:631-654.
8. Laakso M. Insulin resistance and coronary heart disease. Curr Opin Lipidol. 1996;7:217-226.
9. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
10. Juhan-Vague I, Alessi MC. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb Haemost. 1997;78:656-660.
11. Imperatore G, Riccardi G, Iovine C, Rivellese AA, Vaccaro O. Plasma fibrinogen: a new factor of the metabolic syndrome: a population based study. Diabetes Care. 1998;21:649-654.
12. Kario K, Nago N, Kayaba K, Saegusa T, Matsuo H, Goto T, Tsutsumi A, Ishikawa S, Kuroda T, Miyamoto T, Matsuo T, Shimada K, on the behalf of the Jichi Medical School Cohort Study Group. Characteristics of the insulin resistance syndrome in a Japanese population: the Jichi Medical School Cohort Study. Arterioscler Thromb Vasc Biol. 1996;16:269-274.
13. Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati FL, Sharrett AR, Davis CE, Heiss G. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Metabolism. 1996;45: 699-706.
14. Yarnell JW, Patterson CC, Bainton D, Sweetnam PM. Is metabolic syndrome a discrete entity in the general population?: evidence from the Caerphilly and Speedwell population studies. Heart. 1998;79:248-252.
15. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev. 1998; 20:157-172.
16. Diabetes Mellitus. Report of a WHO Study Group. Geneva, Switzerland: World Health Organization; 1985. Technical Report Series No. 727.
17. Saltin B, Grimby G. Physiological analysis of middle-aged and old former athletes. Circulation. 1968;38:1104-1115.
18. Åstrand PO, Ryhming I. A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during submaximal work. J Appl Physiol. 1954;7:218-221.
19. Hyvärinen A, Nikkilä E. Specific determination of blood glucose with o-toluidine. Clin Chim Acta. 1962;7:140-143.
20. Herbert V, Lau KS, Gotlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol. 1965;25:1375-1384.
21. Abell LL, Levy BB, Brodie BB, Kendall FE. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 1952;195:357-366.
22. Björkstén F. Determination of plasma and serum triglycerides with a fully automated method. Clin Chim Acta. 1972;40:143-152.
23. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
24. Walker AE, Robins M, Weinfeld FD. The national survey of stroke: clinical findings. Stroke. 1981;12(suppl I, pt 2):I-13-I-44.
25. Stevens J. Principal components. In: Stevens J, ed. Applied Multivariate Statistics for the Social Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1986:337-350.
26. Lempiäinen P, Mykkänen L, Pyörälä K, Laakso M, Kuusisto J. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation. 1999;100:123-128.
27. Yki-Järvinen H, Koivisto V. Effects of body composition on insulin sensitivity. Diabetes. 1983;32:965-969.
28. Clausen JO, Borch-Johnsen K, Ibsen H, Bergman RN, Hougaard P, Winther K. Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians: analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest. 1996;98:1195-1209.
29. Edwards KL, Austin MA, Newman B, Mayer E, Krauss RM, Selby JV. Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb. 1994;14:1940-1945.
30. Wingard D, Von Muhlen D, Barrett-Connor E, Kritz-Silverstein D. Factor analysis of proposed components of the insulin resistance syndrome. Diabetes. 1996;45(suppl 2):137A. Abstract.
31. Meigs JB, D'Agostino RB, Wilson PWF, Cupples A, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome: the Framingham Offspring Study. Diabetes. 1997;46:1594-1600.
32. Leyva F, Godsland IF, Worthington M, Walton C, Stevenson JC. Factors of the metabolic syndrome: baseline interrelationships in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). Arterioscler Thromb Vasc Biol. 1998;18:208-214.
33. Gray RS, Fabsitz RR, Cowan LD, Lee ET, Howard BV, Savage PJ. Risk factor clustering in the insulin resistance syndrome: the Strong Heart Study. Am J Epidemiol. 1998;148:869-878.
34. Edwards KL, Burchfiel CM, Sharp DS, Curb JD, Rodriguez BL, Fujimoto WY, LaCroix AZ, Vitiello MV, Austin MA. Factors of the insulin resistance syndrome in nondiabetic and diabetic elderly Japanese-American men. Am J Epidemiol. 1998;147:441-447.
35. Kekäläinen P, Sarlund H, Pyörälä K, Laakso M. Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes. Diabetes Care. 1999;22:86-92.
36. Laakso M, Sarlund H, Salonen R, Pyörälä K, Salonen JT, Karhapää P. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb. 1991;11:1068-1076.
37. Agewall S, Fagerberg B, Attwall S, Wendelhag I, Urbanovicius V, Wikstrand A. Carotid artery wall thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke. 1995;26:956-960.
38. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M. Hamman R, Selby JV, Saad MF, Savage P, Bergman R, for the IRAS Investigators. Insulin sensitivity and atherosclerosis. Circulation. 1996;93:1809-1817.
39. Suzuki M, Shinozaki K, Kanazawa A, Hara Y, Hattori Y, Tsushima M, Harano Y. Insulin resistance as an independent risk factor for carotid wall thickening. Hypertension. 1996;28:593-598.
40. Bressler P, Bailey SR, Matsuda M, DeFronzo RA. Insulin resistance and coronary artery disease. Diabetologia. 1996;39:1345-1350.
41. Howard G, Hamman RF, Rewers M, Hiatt W, Haffner S, for the IRAS Investigators. Insulin sensitivity and systemic atherosclerosis. Circulation. 1999;99:1115. Abstract.
42. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab. 1998;83:2773-2776.